Skip to content
★ Sign in to follow
RE

Richard Eberly

Chembio Diagnostics, Inc.Meridian Bioscience Inc
Total declarations
97
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (35 ops.)
€1.9M

Latest filing published 01 May 2023 for CHEMBIO DIAGNOSTICS, INC., €22k.

Insider track record

Disclosed buys
0
Disclosed sells
35
Signal history

Richard Eberly: trading record in brief

Richard Eberly discloses dealings in 2 companies, chiefly Meridian Bioscience Inc and Chembio Diagnostics, Inc. In total, 97 filings cover trades dated from 13 March 2006 to 26 April 2023.

Every open-market trade on record is a sale: 35 sales worth €1.9M. The rest of the record consists of 32 share grants and 17 option exercises.

The newest entry dates from 1 May 2023: an option exercise, in Chembio Diagnostics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Richard Eberly

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations97 total

25 of 97 declarations